WeChat Mini Program

Old Version Features

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

A Phase II Study to Evaluate the Need for > Two Doses of Nivolumab + Ipilimumab Combination (combo) Immunotherapy.

Michael A. Postow,Debra A. Goldman,Alexander Noor Shoushtari,Allison Betof Warner,Margaret K. Callahan,Parisa Momtaz,Ellesa Naito,Omar Eton,Suresh Nair,Jedd D. Wolchok,Katherine Panageas,Paul B. Chapman

JOURNAL OF CLINICAL ONCOLOGY（2020）

Cited 23|Views44

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined